61 results
8-K
EX-2.1
CHRS
Coherus Biosciences Inc
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
Disclosure Schedule.
“Environmental Law” means any applicable Law existing on the date hereof related to pollution or protection of the environment … , emptying, discharging, injecting, escaping, or dumping into or through the environment.
“Remedies Exception” means (a) applicable bankruptcy, insolvency
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
6 Nov 23
Coherus BioSciences Reports Third Quarter 2023 Financial Results and Business Highlights
4:31pm
significantly advanced Coherus’ next-generation immuno-oncology pipeline focused on the tumor micro-environment with clinical stage anti-IL-27 and anti-CCR8
8-K
EX-99.1
u7gw2
2 Aug 23
Coherus BioSciences Reports Second Quarter 2023 Financial Results and Business Highlights
4:05pm
424B3
s97ijah
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
7f2e0
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
5hg0yd8y1lgve2
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
qmb6g0yqwl6zsu
16 Jun 23
Business combination disclosure
8:08am
425
k9x41y
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-2.1
no32 e34f7een5
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
EX-1.1
b1zlyb74kz5ehtu w5
18 May 23
Other Events
5:02pm
8-K
EX-10.1
1efmzj0sa3
7 Jan 22
Coherus BioSciences Secures Credit Financing
8:36am